Mayo-Smith MF, Beecher LH, Fischer TL, et al. Management of alcohol withdrawal delirium. An evidence-based practice guideline. Arch Intern Med. 2004;164:1405-1412. (Meta-analysis of 9 prospective controlled trials, 217 patients)
Bråthen G, Ben-Menachem E, Brodtkorb E, et al. EFNS guideline on the diagnosis and management of alcohol-related seizures: report of an EFNS task force. Eur J Neurol. 2005;12:575-581. (Review)
Ntais C, Pakos E, Kyzas P, et al. Benzodiazepines for alcohol withdrawal (Review). Cochrane Database Syst Rev. 2010;20:1-110. (Meta-analysis of 64 studies; 4309 patients)
Victor M, Brausch C. The role of abstinence in the genesis of alcoholic epilepsy. Epilepsia.1967;8:1-20. (Review)
Daeppen JB, Gache P, Landry U, et al. Symptom-triggered vs fixed-schedule doses of benzodiazepine for alcohol withdrawal: a randomized treatment trial. Arch Intern Med. 2002;162:1117- 1121. (Prospective, randomized; 117 patients)
Saitz R, Mayo-Smith MF, Roberts MS, et al. Individualized treatment for alcohol withdrawal. A randomized double-blind controlled trial. JAMA. 1994;272:519-523. (Randomized double-blind, controlled trial; 101 patients)
Rey E, Treluyer JM, Pons G. Pharmacokinetic optimisation of benzodiazepine therapy for acute seizures. Clinical Pharmacokinetics. 1999;36:409-424. (Review)
Wermeling DP, Miller JL, Archer SM, et al. Bioavailability and pharmacokinetics of lorazepam after intranasal, intravenous, and intramuscular administration. J Clin Pharmacol. 2001;41:1225. (Randomized crossover study; 11 volunteers)
Nobay F, Simon BC, Levitt MA, et al. A prospective, doubleblind, randomized trial of midazolam versus haloperidol versus lorazepam in the chemical restraint of violent and severely agitated patients. Acad Emerg Med. 2004;11:744-749. (Prospective, randomized; 111 patients)
Hung OR, Dyck JB, Varvel J et al. Comparative absorption kinetics of intramuscular midazolam and diazepam. Can J Anaesth.1996;43:450-455. (Prospective, randomized, 3-way crossover; 4 patients)
